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Abstract: Background: Deworming is one of the strategies to reduce the burden of anemia among pregnant
women. Globally, pregnant women in sub-Saharan Africa are more affected by anemia. Therefore, this study
examined both the coverage and demographic, socioeconomic, and women empowerment-related factors
associated with the utilization of deworming medication among pregnant married women in sub-Saharan Africa.
Methods: We used data from the most recent Demographic and Health Surveys of 26 countries in sub-Saharan
Africa conducted between 2010 and 2019. Using Stata version-14 software, analysis was done on 168,910 pregnant
married women. Bivariate and multivariable logistic regression analyses were conducted to examine the factors
associated with the utilization of deworming medication. The results were presented using adjusted odds ratios
(aORs) at 95% confidence intervals (CIs).
Results: The pooled results showed that about 50.7% (95% CI 48.2–53.3%) of pregnant married women in the
studied countries took deworming medications, and this varied from as high as 84.1% in Sierra Leone to as low as
2% in Angola. Regarding sub-regional coverage, the highest and lowest coverages were seen in East Africa (67.6%,
95% CI 66.0–69.1%) and West Africa (24.3%, 95% CI 22.4–26.4%) respectively. We found higher odds of utilization of
deworming medication among older pregnant married women (aOR=1.93, 95% CI 1.32–2.84), women with
educated husbands (aOR=1.40, 95% CI 1.11–1.77), wealthier women (aOR=3.12, 95% CI 1.95–4.99), women exposed
to media (aOR=1.46, 95% CI 1.18–1.80), and those who had four or more antenatal care visits (aOR=1.51, 95% CI
1.24–1.83).
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Conclusions: Enhancing women’s education, disseminating information about maternal healthcare services
through mass media, and ensuring that women from economically disadvantaged households benefit from
national economic growth can be considered as deworming medication improvement strategies in sub-Saharan
Africa. Moreover, providing more attention to adolescents or young pregnant women and increasing the number
of antenatal care visits could be considered to increase deworming uptake among pregnant married women.
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Background
Soil-transmitted helminths (STH) is one of the major
public health problems worldwide [1–6]. Globally, ap-
proximately 1.5 billion people are affected by STH [6].
Majority of women of reproductive age (WRA) including
pregnant women are the most affected [3, 4, 6]. Most of
the disease burden occurs in the tropical and sub-
tropical areas of sub-Saharan Africa (SSA) and South
East Asia [5]. WRA in South East Asian and African re-
gions are responsible for 74.7% of all STH risk among
WRA [3, 4]. Hookworm and whipworm (Trichuris tri-
chiura) are the most common helminths among preg-
nant women [2, 4, 6]. Pregnant women especially are at
particular risk for STH [6, 7]. Pregnant women with in-
testinal parasitic infection are at increased risk of mater-
nal complications and adverse perinatal outcomes such
as anemia, low birth weight, and perinatal mortality [8,
9]. Anemia affects approximately 39% of WRA, including
pregnant women in SSA [10], which is higher than the
average in low- and middle-income countries (LMICs)
(35.4%) and worldwide (33%). The prevalence of anemia
among pregnant women in SSA is 46% [11].
The World Health Organization (WHO) recom-
mended deworming or preventive chemotherapy for
pregnant women after the first trimester, using a single
dose of mebendazole (500 mg) or albendazole (400 mg)
in areas where there is 40% or higher anemia prevalence
among pregnant women and the prevalence of T. Tri-
chiura and hookworm is 20% and above [6, 12, 13]. As
documented in several prior studies, prevention chemo-
therapy or deworming of pregnant women and children
significantly enhances hemoglobin level and nutritional
status [14–16]. Women who are dewormed during preg-
nancy tend to have an improved birth weight [17, 18]
and a reduction in prevalence of low birth weight [19].
In 2001, representatives at the World Health Assembly
universally recognized a determination (WHA54.19) ur-
ging endemic countries to start seriously tackling worms,
specifically schistosomiasis and as a strategy to control
STH in high endemic regions such as SSA [6], and
WHO prepared PC guideline to control STH especially
among 103 STH-endemic countries, and as this is often
a worldwide rule, Part States are anticipated to adjust
the proposal concurring to their setting and its achiev-
ability [20]. In line with this, integrated STH control
strategies were designed in many countries in SSA, al-
though the performance is not satisfactory related to
limited funds to cascade the program [21].
For instance, a few funds have been committed by the
Bill & Melinda Gates Foundation (for backing), the
USAID (up to $100 million, with the probability of more
in a long time to come), the Geneva Worldwide ($8.9
million), and the British Government (up to £50 million
promised for a few NTDs) for ten sub-Saharan African
nations, namely Burkina Faso, Burundi, Ghana, Mali,
Niger, Rwanda, Sierra Leone, Southern Sudan, Tanzania,
and Uganda, to execute their national programs utilizing
coordinates of neglected tropical diseases control. In any
case, the funds accessible are not however adequate for
these nations to scale up totally [21, 22].
To successfully control STH in STH-endemic coun-
tries, establishing an efficient STH control program in
adolescent, pregnant, and lactating WRA is one of the
six targets to be achieved by 2030 [23, 24]. STH control
programs have been successful during the 2010–2020
decade, and a number of STH-endemic countries includ-
ing most SSA countries conducted PC programs for
more than 5 years, although few countries such as
Botswana have not started the program [24].
As of 2017, the coverage of preventive chemotherapy
was <75% in Angola, Chad, Comoros, Democratic Re-
public of the Congo, Ethiopia, Gabon, and Kenya,
whereas Congo, Côte d’Ivoire, Guinea, Liberia, Nigeria,
Uganda, Zambia, and Zimbabwe implemented for less
than 5 years and achieved ≥ 75%. Similarly, Burundi,
Cameroon, Ghana, Malawi, Rwanda, Sierra Leone, and
Togo implemented for 5 years and more and achieved ≥
75% preventive chemotherapy coverage. Few countries
in SSA such as Benin, Burkina Faso, Mali, Niger, and
Senegal recorded the moderate and heavy intensity less
than 1% [24].
Specifically to pregnant women, WHO has set a target
to achieve the coverage of deworming at 75% in 2030 [6,
24]. Available evidence shows that majority of pregnant
women do not receive deworming medication [5]. For
instance, a study in 49 STH endemic countries showed
that about 688 million WRA living in STH endemic
countries were in need of deworming medication as of
2015. However, about only 23% (95% CI 19–28%) of
pregnant women received deworming medication during
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antenatal care (ANC) [5]. Another recent study in
Cameroon shows only 29.8% of pregnant women re-
ceived deworming medication during pregnancy [25].
Few studies on deworming medication are available in
SSA. However, most of the available studies have fo-
cused on the estimation of coverage [5, 26], efficacy,
safety, and tolerability of deworming medication [17]; ef-
fect of mass deworming [7] on schistosomiasis and all
age of population [27], deceptive report [28], and on sin-
gle health facility of a single country [26]. As a result,
there is scarcity of evidence about both coverage and
utilization of deworming medication and its associated
factors among pregnant women in SSA. This study
aimed at examining both the coverage and demographic,
socio-economic, and women empowerment-related fac-
tors associated with the utilization of deworming medi-
cation among pregnant married women in 25
countries in SSA. The current study can help policy
makers to evaluate the implementing policies and pro-
grams or design new policies regarding deworming
medication utilization in the region.
Methods
Study design
This study was a cross-sectional study, and involved
the extraction of data from the Demographic and Health
Survey (DHS) of 26 countries in SSA conducted between
2010 and 2019. DHS is a nationally representative survey
aimed to collect data on demographic and several health
indicators including utilization of deworming medication
across many LMICs [29]. DHS was carried out with fi-
nancial aid from the United States Aid for International
Development (USAID) and technical support of Inner-
City Fund international [30]. During the DHS, a two-
stage stratified cluster sampling technique was applied
[31]. In the first stage, enumeration areas (EAs) also
called clusters were selected from sampling frame pre-
pared from the recent population census. In the second
stage, households (usually 25–30 households) were se-
lected from the clusters. We included 26 countries in
SSA because of the inclusion criteria: availability of
dependent variable and key explanatory variables and
DHS conducted between 2010 and 2019. The analysis
was done on 168,910 pregnant married women. The
DHS datasets are freely available for download at
https://dhsprogram.com/data/available-datasets.cfm. The
reason we limited the analysis to married women was
the inclusion of women empowerment variables which is
applicable to married women as explanatory variables
(women’s decision-making power and wife beating atti-
tude) [32, 33]. We followed the guidelines for Strength-
ening of Observational Studies in Epidemiology
(STROBE) while preparing this manuscript [34]. Please
refer to Table 1, for more details about studied countries
and samples for the study.
Study variables
Dependent variable
The dependent variable of this study was utilization of
deworming medication. The WHO recommends that a
pregnant woman should take a single dose of mebenda-
zole (500 mg) or albendazole (400 mg) after the first tri-
mester [12, 25]. In DHS, women of reproductive age
with birth history in the last 5 years preceding the survey
are asked whether or not they took deworming medica-
tion, and the women responded as yes or no [13, 33].
Then, the dependent variable coded into binary as “yes”
if the women took deworming medication and “no” if
they did not take the deworming medication.
Explanatory variables
Based on available evidence on factors associated with
uptake of deworming medication [5, 7, 17–19, 25–27],
we included the following explanatory variables and cat-
egorized them primarily based on the DHS guide [26]
and also used available studies on same topic. These in-
cluded women’s age (15–19, 20–24, 25–29, 30–34, 35–
39, 40–44, 45–49), women’s educational status (no for-
mal education, primary school, secondary school,
higher), husband’s educational status (no formal educa-
tion, primary school, secondary school, higher), women’s
occupation (not working, professional/technical/man-
agerial, agricultural, manual, others), family size (<5, 5+),
place of residence (urban, rural), religion (Christian,
Muslim, others), timing of antenatal care (ANC) visits
(≤3 months, >3 months), number of ANC visit (<4
months, ≥4 months), and wanted last birth (wanted then,
wanted later, wanted no more). Other variables were
wealth index, media exposure, decision-making power
and attitude towards wife beating. In DHS, wealth index
was computed using durable goods, household charac-
teristics, and basic services following the methodology
explained elsewhere [35], and was further categorized
into five categories: poorest, poorer, middle, richer, and
richest. Media exposure was coded as yes versus no. If
the women read newspaper or listened to the radio or
watched television for at least less than once a week, we
coded as yes and coded as no otherwise.
In the DHS, married women aged 15–49 are asked
three questions to measure their decision-making power
within households: who decides about your own health?
Who decides about large household purchases? Who de-
cides on visit of families or relatives? The questions are
intended to measure the women’s decision-making
power so as to indirectly examine whether or not the
women are empowered or not. If the woman decided
(either alone or together with her husband) on all the
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three aforementioned decision-making parameters, the
woman was considered to have decision-making power,
and was coded as 1, and otherwise considered as no
decision-making power and coded as 0 [32, 33]. Simi-
larly, in the DHS, women of reproductive age are asked
five questions to measure wife beating attitude: do you
agree with wife beating when a woman burns food? Do
you agree with wife beating when a woman goes out
without telling her husband? Do you agree with wife
beating when a woman neglects children? Do you agree
with wife beating when a woman argues with her hus-
band? Do you agree with wife beating when a woman re-
fuses to have sex with her husband? Then, if a woman
responded that a husband was justified for wife beating
for at least one of the five reasons, she was considered as
justifying wife beating and we coded as 0, and if the
woman did not justify/disagreed for all of the five above-
mentioned wife beating reasons, she was considered as
not justifying wife beating and was coded as 1 [32, 33,
36].
Statistical analyses
Using the Stata version 14.0 software, descriptive ana-
lysis such as frequency distribution was carried out to
show the prevalence of deworming medication
utilization. This was followed by Pearson chi-square test
(χ2) and multicollinearity test (using variance inflation
factor (VIF), mean VIF=1.84, max VIF=4.23, min VIF=
1.06). Then, bivariate and multivariable logistic regres-
sion analysis followed by testing model fitness (using
Hosmer-Lemeshow, P=0.3530) was carried out. P-value
less than 0.05 was used as a cutoff point for both







Weighted number Weighted percent
Angola 2015/16 6361 3.77 2.03
Burkina Faso 2010 9964 5.90 24.31
Benin 2017/18 8331 4.93 64.39
Burundi 2016/17 7621 4.51 67.60
Congo Democratic Republic 2013/14 9551 5.65 55.64
Côte d’Ivoire 2011/12 4495 2.66 37.50
Cameroon 2018/19 5013 2.97 29.82
Ethiopia 2016 6662 3.94 5.73
Gabon 2012 2875 1.70 71.58
Ghana 2014 3631 2.15 39.71
Gambia 2013 4974 2.94 40.82
Guinea 2018 5138 3.04 38.07
Kenya 2014 5904 3.50 31.81
Comoros 2012 1878 1.11 63.16
Liberia 2013 4035 2.39 58.56
Mali 2018 6066 3.59 50.15
Malawi 2016/17 11,070 6.55 51.88
Nigeria 2018 14,185 8.40 51.61
Rwanda 2014/15 4741 2.81 49.98
Sierra-Leone 2019 6090 3.61 84.10
Senegal 2010/11 7571 4.48 25.01
Chad 2014/15 10,248 6.07 23.31
Togo 2013/14 4556 2.70 57.16
Uganda 2016 8429 5.00 60.50
Zambia 2018/19 5496 3.25 77.76
Zimbabwe 2015 4025 2.38 3.57
Total 168,910 100.00
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Table 2 Frequency distribution of study participants and deworming distribution across explanatory variables: evidence from 26
sub-Saharan African countries DHSs
Variables Number
(weighted %)
Deworming medication (weighted %) Chi-square,
P-valueNo Yes
Age in years χ2=75.01, p<0.001
15–19 17,193 (7.86) 62.99 37.01
20–24 44,508 (19.88) 52.28 47.72
25–29 55,243 (21.60) 44.80 55.20
30–34 47,557 (16.88) 46.00 54.00
35–39 40,591 (14.56) 47.03 52.97
40–44 29,250 (11.73) 47.94 52.06
45–49 22,617 (7.51) 63.62 36.38
Women’s educational status χ2=615.81, p<0.001
No formal education 112,216 (27.46) 69.86 30.14
Primary school 80,241 (38.90) 50.82 49.18
Secondary school 54,423 (29.65) 30.77 69.23
Higher 10,069 (3.98) 22.70 77.30
Husband’s educational status χ2=571.32, p<0.001
No formal education 96,580 (21.13) 66.22 33.78
Primary school 62,425 (26.62) 62.78 37.22
Secondary school 67,653 (44.91) 36.57 63.43
Higher 19,207 (7.34) 24.54 75.46
Women’s occupation χ2=662.67, p<0.001
Not working 58,510 (25.30) 42.32 57.68
Professional/technical/managerial 9,517 (5.41) 33.64 66.36
Agricultural 79,991 (29.67) 73.21 26.79
Manual 16,683 (3.39) 40.35 59.65
Others 74,493 (36.23) 36.48 63.52
Wealth index χ2=1187.29, p<0.001
Poorest 58,177 (17.92) 80.63 19.37
Poorer 53,642 (20.66) 67.28 32.72
Middle 50,997 (20.72) 44.33 55.67
Richer 48,109 (20.59) 29.96 70.04
Richest 46,034 (20.11) 21.83 78.17
Media exposure χ2=703.03, p<0.001
No 115,882 (28.22) 74.96 25.04
Yes 140,589 (71.78) 38.51 61.49
Family size χ2= 20.43, p<0.01
<5 78,802 (33.09) 53.6 46.40
5+ 178,157 (66.91) 47.41 52.59
Religion χ2=40.13, p<0.001
Christian 145,994 (93.53) 48.23 51.77
Muslim 100,493 (0.36) 46.09 53.91
Others 10,885 (6.11) 64.36 35.64
ANC follow-up χ2=1257.17, p<0.001
No 21,703 (18.33) 96.17 3.83
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bivariate and multivariable logistic regression. To take
care of the complex nature of the DHS’s data, we used
the “svyset” command during analysis, and all three de-
sign elements such as weight, cluster, and strata were
taken into consideration.
Ethical considerations
We used publicly available secondary data for analysis of
this study (available at https://dhsprogram.com/data/
available-datasets.cfm.). Ethical procedures were done by
institutions that fund, commissioned, and managed the
surveys, and no further ethical clearance was required.
ICF international approved that all the DHS surveys fol-
low the US Department of Health and Human Services
rules, for respecting of human subject’s rights. For more
details related to ethical issues, readers can visit http://
goo.gl/ny8T6X.
Results
Sociodemographic characteristics of respondents
As shown in Table 2, a total of 168,910 participants were
involved for analysis of this study. Of them, 7.9% of
respondents were within 15–19 years while about 27.5%
of respondents and 21.1% of their husbands did not at-
tend formal education respectively. Approximately three
quarters (25.3%) of the respondents were not working,
and 35.3% were rural residents. Meanwhile, 34.6% of
married women had not decided for at least one reason
of decision-making parameters: their own health, pur-
chase large household expenses, and to visit families or
relatives. About 28.6% of married women agreed or jus-
tified for wife beating for at least one of the five wife
beating reasons.
Utilization of deworming medication
The pooled results show that more than half (50.74%,
95% CI 48.15–53.31%) of married women in the studied
countries in SSA took deworming medications. As
shown in Fig. 1, highest utilization coverage of deworm-
ing medication were seen in Sierra-Leone (84.1%),
Zambia (77.8%), and Gabon (71.6%) respectively, and
lowest coverage was reported in Angola (2%), Zimbabwe
(3.6%), and Ethiopia (5.7%) respectively (Fig. 1).
Table 2 Frequency distribution of study participants and deworming distribution across explanatory variables: evidence from 26
sub-Saharan African countries DHSs (Continued)
Variables Number
(weighted %)
Deworming medication (weighted %) Chi-square,
P-valueNo Yes
Yes 159,944 (81.67) 38.73 61.27
Timing of first ANC χ2=60.41, p<0.001
>3 months 98,455 (51.38) 43.93 56.07
≤3 months 61,501 (48.62) 33.23 66.77
Number of ANC visit χ2=162.01, p<0.001
<4 months 68,864 (24.89) 53.94 46.06
≥4 months 91,080 (75.11) 33.69 66.31
Wanted last birth χ2=20.00, p<0.05
Wanted then 134,087 (66.01) 51.26 48.74
Wanted later 30,712 (27.97) 45.11 54.89
Wanted no more 10,340 (6.02) 46.67 53.33
Decision making capacity χ2=22.02, p<0.01
No 146,584 (34.59) 53.21 46.79
Yes 100,136 (65.41) 47.07 52.93
Wife beating attitude χ2=107.32, p<0.001
Agreed for wife beating 120,487 (28.60) 59.26 40.74
Disagreed for wife beating 126,324 (71.40) 45.04 54.96
Barrier to healthcare services χ2=82.83, p<0.001
No 83,661 (30.50) 40.57 59.43
Yes 154,366 (69.50) 53.01 46.99
Place of residence χ2=801.94, p<0.001
Urban 83,181 (64.71) 35.82 64.18
Rural 173,778 (35.29) 72.71 27.29
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As shown in Table 3, wide differences in utilization of
deworming medication across sub-African regions are
seen with highest coverage in East Africa (67.6%, 95% CI
66.0–69.1%) region followed by Central Africa (50.7%,
95% CI 48.2–53.3%) and lowest coverage in West Africa
(24.3%, 95% CI 22.4–26.4%) (Table 3).
Utilization of deworming medication across explanatory
variables
Table 2 shows variations in utilization coverage of
deworming medication across explanatory variables and
subcategories. For instance, utilization of deworming
medication varied from 30.1 to 77.3% between married
women who had not attended formal education and
those who had attended higher education, respectively
(Fig. 2).
Similarly, among married women between poorest
and richest subpopulation, utilization of deworming
medication varied from 19.4 to 78.2%, respectively
(Fig. 3).
About 61.5% of married women who had media ex-
posure were taking deworming medication, while not
more than of 25% of married women who had no
media exposure took deworming medication. More-
over, about 61.5% of married who were exposed to
media, could it be newspaper, radio, or television,
took deworming medication, but the coverage lowered
to 25% among married women with no media expos-
ure. Utilization of deworming medication also varied
from 46.1 to 66.3% between married women with less
than four ANC visits and four and above ANC visits
respectively (Table 2).
Fig. 1 Utilization coverage of deworming medication among married women: evidence from 25 SSA countries DHSs
Zegeye et al. Tropical Medicine and Health           (2021) 49:53 Page 7 of 15
Factors associated with utilization of deworming
medication
Table 4 shows bivariate and multivariable logistic regres-
sion analysis of factors associated with utilization of
deworming medication. The bivariate analysis shows
that women’s age, women’s educational status, husband’s
educational status, women’s occupation, wealth index,
media exposure, family size, place of residence, barriers
to healthcare services, religion, timing of ANC visit,
number of ANC visit, wanted last birth, wife beating at-
titude, and decision making were associated with
utilization of deworming medication. However, the mul-
tivariable analysis shows that women’s age, husband’s
educational status, wealth index, media exposure, and
number of ANC visit were factors associated with
utilization of deworming medication.
More specifically, we found higher odds of utilization
of deworming medication among married women within
the age groups of 25–29 years (aOR=1.57, 95% CI 1.13–
2.18), 30–34 years (aOR=1.58, 95% CI 1.10–2.28), 35–39
years (aOR=1.93, 95% CI 1.32–2.84), and 40–44 years
(aOR=1.92, 95% CI 1.25–2.95) compared to married
women within 15–19 years of age. The study shows
higher odds of utilization of deworming medication
among married women whose husband attended sec-
ondary school (aOR=1.40, 95% CI 1.11–1.77) compared
to married women whose husband did not attend formal
education.
Moreover, higher odds of utilization of deworming
medication were observed among married women in the
middle (aOR=1.77, 95% CI 1.24–2.51), richer (aOR=2.39,
95% CI 1.55–3.69), and richest (3.12, 95% CI 1.95–4.99)
households compared to married women in the poorest
households. We found higher odds of utilization of
deworming medication among married women who had
media exposure (aOR=1.46, 95% CI 1.18–1.80) com-
pared to married women who had no media exposure.
Finally, in this study, there were higher odds of
Table 3 Coverage of utilization of deworming medication among pregnant married women by sub-regions: evidence from 26 sub-
Saharan African countries DHSs
Sub-regions Included countries Pooled sub-regional coverage


























Notes: CI confidence interval
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utilization of deworming medication among married
women who had four and above ANC visits (aOR=1.51,
95% CI 1.24–1.83) compared to married women who
had less than four ANC visits (Table 4).
Discussion
In this study, using nationally representative data, we in-
vestigated the coverage and sociodemographic, socioeco-
nomic, and women empowerment-related factors
associated with deworming medication utilization
among pregnant married women in 26 sub-Saharan Af-
rican countries. The pooled result shows that more than
half (50.74%) of married women in the studied countries
took deworming medications. The finding from this
study was higher compared to the study conducted
among 49 STH endemic countries that showed 23% of
pregnant women received deworming medication [5].
The variations in the coverage of utilization of deworm-
ing medication between these two studies might partly
relate to variation in methodology of the studies (mar-
ried women versus all reproductive age women, and
study area/included countries). In this study, utilization
coverage of deworming medication varied from as high
as 84.1% in Sierra-Leone to as low as 2% in Angola.
Concerning sub-African region variations, highest and
lowest coverage of utilization of deworming medication
among pregnant married women was seen in East Africa
(67.6%) and West Africa (24.3%) regions respectively.
The variations across African regions and countries
might be related to factors associated with utilization of
deworming medication such as socioeconomic factors
[16–18] and time effect (the year when the DHS data
was collected across countries; 2010 to 2019).
Women’s age was associated with utilization of
deworming medication. More specifically, we found
higher odds of utilization of deworming medication
among older married women compared to adolescent
married women. The plausible reason could be higher
educational and career accomplishment as well as better
family income which increase with age [37, 38]. Older
women usually are proactive, and they emphasize on
prevention of diseases [37, 39], which could be related to
their previous experience [37].
The study showed higher odds of utilization of
deworming medication among married women whose
husbands were educated, compared to married women
whose husbands did not have formal education. Women
with educated husbands have better uptake of maternal
health services due to the fact that educated husbands
participate in promoting their wives’ health and have
positive relationship with their wives [40]. In addition,
educated husbands are more likely to encourage their
wives to seek and utilize healthcare services during preg-
nancy [41]. On the other hand, husbands with no formal
education may prevent their wives from utilizing health
services due to being uncomfortable with touching or
examining their wives [42]. The other reason about hus-
band’s education effect is its linkage with income and
wealth [43]. Scholars have documented that education is
the noticeable factor to get employment opportunities,
earn better, and increase individual, communities, and
national economic growth [44–46] that again has posi-
tive influence in accessing healthcare services [47, 48].
Hence, to use the positive impact of husband education,
increasing national education coverage, husband-
oriented health education programs, and involvement of
husband in maternal healthcare services may be the pol-
icy recommendations [49, 50].
Moreover, the study showed higher odds of utilization
of deworming medication among married women from
higher socio-economic households compared to mar-
ried women in the poorest households. This finding is
Fig. 2 Utilization of deworming medication among pregnant women based on educational level: evidence from 26 sub-Saharan African
countries DHSs
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comparable with a prior study in Ghana [51]. Com-
pared to wealthier women, economically disadvan-
taged women encounter problems in accessing
healthcare services due to direct costs such as pay-
ment for medication that may include the possibility
of paying for medication in the time when stock runs
out from the dispensary and indirect costs such as
transport costs and unpaid working hours [40, 47, 48,
52]. Unfortunately, the burden of helminthic infection
and its consequences, anemia, is more prevalent
among individual or communities within countries of
low socioeconomic status such as South East Asia
and Africa [53–55]. Therefore, giving attention to
women in economically disadvantaged households
could be one intervention mechanism for enhance-
ment of uptake of deworming medication.
Pregnant women need correct information about
healthcare services, and it can help them to have in-
formation about the available healthcare services and
their needs through visual appealing, audio message,
and printed reports [42, 56]. In this study, we found
higher odds of utilization of deworming medication
among married women who were exposed to media,
compared to married women who had no media ex-
posure. Prior studies in India [57], Bangladesh [58],
South Asia [42], Uganda [59], and Malawi [60] docu-
mented the influence of media on maternal health
services. Mass media could have tremendous role in
the dissemination of health-related information and
development of knowledge for mothers especially for
those population groups with less education and those
who live in rural setting [42, 57]. Therefore, media-
focused regional and national public health policies
and practices including prepare campaign and on-
going health education programs using mass media
need to be considered to increase the uptake of
deworming medication [61].
We found higher odds of utilization of deworming
medication among married women who had four and
above ANC visits compared to married women who
had less than four ANC visits. ANC visit is a good
opportunity to receive deworming medication because
more information about benefits of deworming and
positive pregnancy outcomes are gained through
counseling during repeated ANC visits [13]. There-
fore, governments should reduce or eliminate barriers
that limit number of ANC visits such as long distance
to health facilities that may be aggravated by difficult
geographical/road conditions [62], and strengthening
the use of ANC services in the region as newly rec-
ommended by WHO is expected from the health sec-
tor and needs to become an agent to coordinate and
work with other sectors so as to enhance uptake of
deworming medication among pregnant women.
In this study, women’s decision-making power and
wife beating attitude was not associated with uptake
of deworming medication. This might indirectly tell
us access to and utilization of maternal healthcare
services among married women are strongly
determined by husband educational level [63]. More-
over, gender inequity such as husband’s financial sta-
tus within the household might determine the
uptake of maternal health services [64]. In fact, get-
ting permission from husband is one of the four
Fig. 3 Utilization of deworming medication among pregnant women based on household economic status: evidence from 26 sub-Saharan
African countries DHSs
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Table 4 Bivariate and multivariable logistic regression output for factors associated with utilization of deworming medication
among married women: evidence from 26 SSA countries DHSs
Variables Model I cOR [95% CI) P-value Model II aOR [95% CI) P-value
Age in years
15–19 Ref Ref
20–24 1.55 (1.17–2.05) 0.002 1.27 (0.91–1.78) 0.147
25–29 2.09 (1.59–2.74) p<0.001 1.57 (1.13–2.18) 0.007
30–34 1.99 (1.48–2.67) p<0.001 1.58 (1.10–2.28) 0.013
35–39 1.91 (1.42–2.57) p<0.001 1.93 (1.32–2.84) 0.001
40–44 1.84 (1.26–2.70) 0.002 1.92 (1.25–2.95) 0.003
45–49 0.97 (0.59–1.60) 0.914 1.15 (0.63–2.11) 0.630
Women’s educational status
No formal education Ref Ref
Primary school 2.24 (1.84–2.73) p<0.001 1.03 (0.81–1.30) 0.791
Secondary school 5.21 (4.15–6.54) p<0.001 1.04 (0.77–1.39) 0.786
Higher 7.89 (4.73–13.16) p<0.001 1.00 (0.53–1.88) 0.992
Husband’s educational status
No formal education Ref Ref
Primary school 1.16 (0.91–1.47) 0.214 1.10 (0.86–1.40) 0.435
Secondary school 3.40 (2.76–4.17) p<0.001 1.40 (1.11–1.77) 0.004
Higher 6.02 (4.13–8.79) p<0.001 1.28 (0.86–1.91) 0.214
Women’s occupation
Not working Ref Ref
Professional/technical/managerial 1.44 (0.94–2.20) 0.085 0.86 (0.53–1.40) 0.554
Agricultural 0.26 (0.21–0.33) p<0.001 0.85 (0.67–1.07) 0.181
Manual 1.08 (0.72–1.62) 0.695 0.86 (0.54–1.36) 0.521
Others 1.27 (1.03–1.57) 0.024 0.99 (0.78–1.25) 0.978
Wealth index
Poorest Ref Ref
Poorer 2.02 (1.54–2.65) p<0.001 1.32 (0.97–1.80) 0.071
Middle 5.22 (3.87–7.04) p<0.001 1.77 (1.24–2.51) 0.001
Richer 9.73 (7.11–13.31) p<0.001 2.39 (1.55–3.69) p<0.001
Richest 14.90 (10.40–21.35) p<0.001 3.12 (1.95–4.99) p<0.001
Media exposure
No Ref Ref
Yes 4.77 (3.96–5.76) p<0.001 1.46 (1.18–1.80) p<0.001
Family size
<5 Ref Ref
5+ 1.28 (1.09–1.49) 0.002 1.13 (0.93–1.39) 0.197
Place of residence
Urban Ref Ref
Rural 0.20 (0.16–0.26) p<0.001 0.98 (0.74–1.30) 0.935
Barriers to healthcare services
No Ref Ref
Yes 0.60 (0.50–0.72) p<0.001 0.87 (0.72–1.07) 0.200
Religion
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main barriers to access healthcare services [47, 48].
Several prior studies also documented the strong as-
sociation between husband education and/or involve-
ment with uptake of maternal health service
utilization [65–67]. Therefore, considering designing
policies that target on enhancing husband education
coverage and involvements help to increase the up-
take of maternal health services including deworming
medication [64, 67].
Strengths and limitations of the study
Determining utilization coverage of deworming medi-
cation and investigating its demographic, socioeco-
nomic, and women empowerment-related factors
among pregnant married women using nationally rep-
resentative, large sample size and across several coun-
tries (25 countries in SSA) is the main strength of
this study. The findings of this study could be used
by policy makers to improve the uptake of deworm-
ing medication in SSA. In terms of limitations, al-
though we attempted to incorporate many countries,
due to the inclusion criteria, we only included few
countries in SSA, and the findings may not be
generalizable to all sub-Saharan African countries.
Moreover, since we were interested in examining
women empowerment-related factors, which are ap-
plicable to married women only, we could not include
non-married women, and therefore, findings are lim-
ited to married women. Third, the cross-sectional na-
ture of the study could not allow for inferring causal-
effect relationship. Lastly, the time when the surveys
were conducted varied by up to 9 years across studied
countries and that needs to be considered as it may
affect the comparisons due to the time effect.
Conclusion
The pooled results show that about half of married
women received deworming medication during their
pregnancy. Women’s age, husband’s educational sta-
tus, wealth index, media exposure, and number of
ANC visits were factors associated with utilization of
deworming medication. Therefore, enhancing women’s
education, involving men in women’s health pro-
grams, accessing women’s use of media especially
Table 4 Bivariate and multivariable logistic regression output for factors associated with utilization of deworming medication
among married women: evidence from 26 SSA countries DHSs (Continued)
Variables Model I cOR [95% CI) P-value Model II aOR [95% CI) P-value
Christian Ref Ref
Muslim 1.08 (0.29–3.98) 0.897 1.73 (0.23–12.94) 0.592
Others 0.51 (0.35–0.74) p<0.001 1.04 (0.71–1.51) 0.824
ANC follow-up
No Ref - -
Yes 39.74 (26.60–59.37) p<0.001 - -
Timing of ANC visit
>3 months Ref Ref
≤3 months 1.57 (1.32–1.86) p<0.001 1.09 (0.91–1.31) 0.303
Number of ANC visit
<4 month Ref Ref
≥4 month 2.30 (1.92–2.76) p<0.001 1.51 (1.24–1.83) p<0.001
Wanted last birth
Wanted then Ref Ref
Wanted later 1.27 (1.08–1.51) 0.004 1.01 (0.83–1.22) 0.901
Wanted no more 1.20 (0.87–1.64) 0.249 1.06 (0.75–1.48) 0.731
Wife beating attitude
Agreed for wife beating Ref Ref
Disagreed for wife beating 1.77 (1.49–2.11) p<0.001 1.19 (0.99–1.43) 0.056
Decision-making capacity
No Ref Ref
Yes 1.27 (1.07–1.52) 0.007 1.10 (0.90–1.35) 0.340
Notes: Ref reference
Hyphen (-) indicates not included variable at model II due to small proportion of subgroups
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those who are not literate and living in rural areas
and disseminating information about maternal health-
care services through mass media, and ensuring that
economically disadvantaged households benefit from
national economic growth can be considered as policy
measures. Moreover, providing more attention to ado-
lescent or young pregnant women and strengthening
ANC services including increasing number of ANC
visits can be another solution for increased uptake of
deworming medication among married pregnant
women especially in West African countries.
Abbreviations
CI: Confidence intervals; DHS: Demographic and Health Surveys; STH: Soil-
transmitted helminthiasis; WHO: World Health Organization
Acknowledgements
The authors thank the MEASURE DHS project for their support and for free




SY and BZ contributed to the study design and conceptualization. BZ
reviewed the literature and performed the analysis. MK, BOA, EKA, AS, and SY
provided technical support and critically reviewed the manuscript for its
intellectual content. SY had final responsibility to submit for publication. The
authors read and amended drafts of the paper and approved the final
version.
Funding
There was no funding for this study.
Availability of data and materials
Data for this study were sourced from the Demographic and Health surveys
(DHS) and available here: http://dhsprogram.com/data/available-datasets.cfm.
Ethics approval and consent to participate
Ethics approval was not required for this study since the data is secondary
and is available in the public domain. More details regarding DHS data and
ethical standards are available at http://goo.gl/ny8T6X.
Consent for publication
No consent to publish was needed for this study as we did not use any
details, images, or videos related to individual participants. In addition, data
used are available in the public domain.
Competing interests
The authors declare that they have no competing interests.
Author details
1HaSET Maternal and Child Health Research Program, Shewarobit Field Office,
Shewarobit, Ethiopia. 2Department of Population Studies, Faculty of Social
Sciences, University of Botswana, Private Bag, UB 0022 Gaborone, Botswana.
3School of Public Health, Faculty of Health, University of Technology Sydney,
Sydney, NSW 2007, Australia. 4Department of Population and Health,
University of Cape Coast, Cape Coast PMB 0494, Ghana. 5College of Public
Health, Medical and Veterinary Sciences, James Cook University, Townsville,
QLD 4811, Australia. 6School of International Development and Global
Studies, Faculty of Social Sciences, University of Ottawa, 120 University
Private, Ottawa, ON K1N 6N5, Canada. 7The George Institute for Global
Health, Imperial College London, London, UK.
Received: 27 April 2021 Accepted: 9 June 2021
References
1. World Health Organization. (2013b). Soil-transmitted helminth infections-
fact sheet No. 366, Available at: http://www.sciepub.com/reference/328233.
Accessed on 07 Apr 2021.
2. Pullan RL, Smith JL, Jasrasaria R, Brooker SJ. Global numbers of infections
and disease burden of soil transmitted helminth infections in 2010. Parasit
Vectors. 2014;7(1):37.
3. Mupfasoni D. Estimation of the number of women of reproductive age in
need of preventive chemotherapy for soil-transmitted helminth (STH)
infections. PLoS Negl Trop Dis. 2018;12(2):e0006269.
4. Report of the WHO Advisory Group on deworming in girls and women of
reproductive age. Rockefeller Foundation Bellagio Center, Bellagio, Italy. 28–
30 June 2017 (WHO/ CDS/NTD/PCT/2018.01). Geneva: World Health
Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
5. Bangert M, Bancalari P, Mupfasoni D, Mikhailov A, Gabrielli AF, Montresor A.
Provision of deworming intervention to pregnant women by antenatal
services in countries endemic for soil-transmitted helminthiasis. PLoS Negl
Trop Dis. 2019;13(5):e0007406.
6. WHO. Soil-transmitted helminth infections, 2020. Available at: https://www.
who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections.
Accessed on 07 Apr 2021.
7. Salam RA, Cousens S, Welch V, Gaffey M, et al. Mass deworming for soil-
transmitted helminthes and schistosomiasis among pregnant women: a
systematic review and individual participant data meta-analysis. Campbell
Syst Rev. 2019;15(3):e1052.
8. Ahenkorah B, Nsiah K, Baffoe P, Ofosu W, Gyasi C, Owiredu E-W. Parasitic
infections among pregnant women at first antenatal care visit in northern
Ghana: a study of prevalence and associated factors. PLoS ONE. 2020;15(7):
e0236514.
9. Paranjpe S, Roopa N, Avani K, Gita N, Preeti M. Prevalence of intestinal
parasites in pregnant women. Indian J Microbiol Res. 2020;7(4):350–7.
10. World Bank. Prevalence of anemia among reproductive age (% of women
ages 15-49). Available at: https://data.worldbank.org/indicator/SH.ANM.A
LLW.ZS. Accessed on 07, Apr 2021
11. World Bank. Prevalence of anemia among pregnant women (%) - Sub-
Saharan Africa | Data. Available at: https://data.worldbank.org/indicator/SH.
PRG.ANEM?locations=ZG. Accessed on May 22, 2021
12. WHO. e-Library of Evidence for Nutrition Actions (eLENA) Deworming in
pregnant women, 2019. Available from: https://www.who.int/elena/titles/
deworming_pregnancy/en/. Accessed on 07, Apr 2020
13. WHO. WHO recommendations on antenatal care for a positive pregnancy
experience. Geneva: World Health Organization; 2016.
14. Larocque R, Gyorkos TW. Should deworming be included in antenatal
packages in hookworm-endemic areas of developing countries? Can J
Public Health. 2006;97(3):222–4.
15. Christian P, Khatry SK, West KP. Antenatal anthelmintic treatment, birth
weight, and infant survival in rural Nepal. Lancet.
2004;364(9438):981–3.
16. Atukorala TM, de Silva LD, Dechering WH, Dassenaeike TS, Perera RS.
Evaluation of effectiveness of iron-folate supplementation and
anthelminthic therapy against anemia in pregnancy— a study in the
plantation sector of Sri Lanka. Am J Clin Nutr.
1994;60(2):286–92.
17. Lau R, Chris RB, Phuong MS, Khatib A, Kopalakrishnan S, Bhasker S, et al.
Treatment of soil-transmitted helminth infections in pregnancy: a systematic
review and meta-analysis of maternal outcomes. J Travel Med. 2020;27(2):
taz079.
18. Walia B, Kmush BL, Lane SD, Endy T, Montresor A, Larson DA. Routine
deworming during antenatal care decreases risk of neonatal mortality and
low birth weight: a retrospective cohort of survey data. MedRxiv (PREPRINT).
2020.
19. de Silva NR, Sirisena JL, Gunasekera DP, Ismaill MM, de Silva HJ. Effect of
mebendazole therapy during pregnancy on birth outcome. Lancet. 1999;
353(9159):1145–9.
20. Guideline: preventive chemotherapy to control soil-transmitted helminth
infections in at-risk population groups. Geneva: World Health Organization;
2017. Licence: CC BY-NC-SA 3.0 IGO.
Zegeye et al. Tropical Medicine and Health           (2021) 49:53 Page 13 of 15
21. Fenwick A, Zhang Y, Stoever K. Control of the neglected tropical diseases in
sub-Saharan Africa: the unmet needs. Int Health. 2009;1(1):61–70. https://doi.
org/10.1016/j.inhe.2009.06.002.
22. Hotez PJ, Molyneux DH, Fenwick A, Savioli L, Takeuchi T. A global fund to
fight neglected tropical diseases: is the G8 Hokkaido Toyako 2008 Summit
ready? PLoS Negl Trop Dis. 2008;2(3pg):e220.
23. Vegvari C, Giardina F, Bajaj S, Malizia V, Hardwick RJ, Truscott JE, et al.
Deworming women of reproductive age during adolescence and
pregnancy: what is the impact on morbidity from soil-transmitted
helminths infection? Parasit Vectors. 2021;14:220. https://doi.org/10.1186/s13
071-021-04620-w.
24. WHO. Neglected tropical diseases. 2030 targets for soil-transmitted
helminthiases control programmes. Geneva: World Health Organization;
2019. License: CC BY-NC-SA 3.0IGO
25. Zegeye B, Ahinkorah BO, Ameyaw EK, Seidu A-A, Yaya S. Utilization of
deworming drugs and its individual and community level predictors among
pregnant married women in Cameroon: a multilevel modeling. Biomed Res
Int. 2021;6645336:12. https://doi.org/10.1155/2021/6645336.
26. Shiferaw MB, Zegey AM, Mengistu AD. Helminth infections and practice of
prevention and control measures among pregnant women attending
antenatal care at Anbesame health center, Northwest Ethiopia. BMC Res
Notes. 2017;10:274.
27. Torres-Vitolas CA, Dhanani N, Fleming FM. Factors affecting the uptake of
preventive chemotherapy treatment for schistosomiasis in Sub-Saharan
Africa: a systematic review. PLoS Negl Trop Dis. 2021;15(1):e0009017.
28. Gyorkos TW, Montresor A, Belizario V, Biggs B-A, Bradley M, Brooker SJ, et al.
The right to deworming: the case for girls and women of reproductive age.
PLoS Negl Trop Dis. 2018;12(11):e0006740.
29. DHS Program. Methodology: survey type. Available at: https://dhsprogram.
com/methodology/survey-Types/dHs.cfm. Accessed on 27 March 2021.
30. The DHS Program- quality information to plan, monitor and improve
population, health, and nutrition programs. Available at: https://dhsprogram.
com/. Accessed on 27 March 2021
31. DHS Program. Guide to DHS statistics. Analyzing DHS data. Available at:
https://dhsprogram.com/data/Guide-to-DHS-Statistics/Analyzing_DHS_Data.
htm. Accessed on 12 March 2021.
32. Kishor S, Subaiya L. Understanding women’s empowerment: a comparative
analysis of Demographic and Health Surveys (DHS) data. DHS Comparative
Reports No. 20. Calverton, Maryland, USA: Macro International Inc.; 2008.
Available at: https://dhsprogram.com/publications/publication-cr20-compara
tivereports.cfm. Accessed on May 29, 2021
33. Trevor NC, Marshall AMJ, Allen CK. Guide to DHS statistics. Rockville: ICF;
2018. Available at: https://dhsprogram.com/data/Guide-to-DHS-Statistics/
index.cfm. Accessed on May 29, 2021
34. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke
JP. The strengthening the reporting of observational studies in
epidemiology (STROBE) statement: guidelines for reporting observational
studies. Int J Surg. 2014;12(12):1495–9.
35. Rutsein SO, Johnson K. The DHS wealth index. DHS Comparative Reports
No. 6. Calverton: ORC Macro; 2004.
36. Yaya S, Zegeye B, Ahinkorah BO, Seidu A-A, Ameyaw EK, Adjei NK, et al.
Predictors of skilled birth attendance among married women in Cameroon:
further analysis of 2018 Cameroon Demographic and Health Survey. Reprod
Health. 2021;18:70. https://doi.org/10.1186/s12978-021-01124-9.
37. Kato T, Yorifuji T, Yamakawa M, Inoue S, Doi H, Eboshida A, et al. Association
of maternal age with child health: a Japanese longitudinal study. PLoS ONE.
2017;12(2):e0172544. https://doi.org/10.1371/journal.pone.0172544.
38. Benzies K, Tough S, Tofflemire K, Frick C, Faber A, Newburn-Cook C. Factors
influencing women’s decisions about timing of motherhood. J Obstet
Gynecol Neonatal Nurs. 2006;35(5):625–33.
39. Nelson AM. A qualitative study of older first-time mothering in the first year.
J Pediatr Health Care. 2004;18(6):284–91. https://doi.org/10.1016/S0891524
504000896.
40. Shibre G, Zegeye B, Idriss-Wheeler D, Sanni YS. Factors affecting the
utilization of antenatal care services among women in Guinea: a
population-based study. Fam Pract. 2020:1–7.
41. Adjiwanou V, Bougma M, LeGrand T. The effect of partners’ education on
women’s reproductive and maternal health in developing countries. Soc Sci
Med. 2018;197:104–15.
42. Fatemaa K, Lariscy JT. Mass media exposure and maternal healthcare
utilization in South Asia. SSM-Population Health. 2020;11:100614.
43. Wolla SA, Sullivan J. Education, income, and wealth: PAGE ONE
Economics; 2017. Available online: https://research.stlouisfed.org/publica
tions/page1-econ/2017/01/03/education-income-wealth/. Accessed on 5
April 2021
44. Grant C. The contribution of education to economic growth. Knowledge,
Evidence and Learning for Development; Helpdesk Report. Brighton:
Institute of Development Studies; 2017.
45. Hanushek EA, Woessmann L. Do better schools lead to more growth?
Cognitive skills, economic outcomes, and causation. J Econ Growth. 2012;17:
267–321.
46. Cloete N. Higher education and economic development in Africa. In:
Vucasovic M, Maassen P, Nerland M, Stensaker B, Pinheiro R, Vabo A, editors.
Effects of higher education reforms. Higher Education Research in the 21st
Century Series. Rotterdam: Sense Publishers; 2012. p. 4.
47. WHO. In: World Health Organization, editor. Barriers and facilitating factors
in access to health services in Greece barriers and facilitating factors in
access to health services in Greece. Copenhagen; 2015.
48. Zegeye B, El-Khatib Z, Ameyaw EK, Seidu A-A, Ahinkorah BO, Keetile M, et al.
Breaking barriers to healthcare access: a multilevel analysis of individual-
and community-level factors affecting women’s access to healthcare
services in Benin. Int J Environ Res Public Health. 2021;18:750. https://doi.
org/10.3390/ijerph18020750.
49. Teklesilasie W, Deressa W. Barriers to husbands’ involvement in maternal
health care in Sidama zone, Southern Ethiopia: a qualitative study. BMC
Pregnancy Childbirth. 2020;20:21.
50. Mullany BC, Becker S, Hindin MJ. The impact of including husbands in
antenatal health education services on maternal health practices in urban
Nepal: results from a randomized controlled trial. Health Educ Res. 2007;
22(2):166–76.
51. Lumor O, Dzabeng F, Adanu RM. Factors influencing the use of anemia
preventing measures among antenatal clinic attendees in the Kintampo
North Municipality, Ghana. Afr J Reprod Health. 2019;23(2):35.
52. Zegeye B, Ahinkorah BO, Idriss-Wheelr D, Oladimeji O, Olorunsaiye CZ, Yaya
S. Predictors of institutional delivery service utilization among women of
reproductive age in Senegal: a population-based study. Arch Public Health.
2021;79:5. https://doi.org/10.1186/s13690-020-00520-0.
53. WHO. Preventive chemotherapy in human helminthiasis: coordinated use of
antihelminthic drugs in control interventions: a manual for health
professionals and programme managers. Geneva: World Health
Organization; 2006. Available from: http://apps.who.int/iris/bitstream/1
0665/43545/1/9241547103_eng.pdf. Accessed on 07, Apr 2020
54. WHO. The global prevalence of anaemia in 2011. Geneva: World Health
Organization; 2015. Available from: http://apps.who.int/iris/bitstream/1
0665/177094/1/9789241564960_eng.pdf. Accessed on 07 Apr 2020
55. WHO. State of inequality: reproductive, maternal, newborn and child health.
Geneva: World Health Organization; 2015. Available from: http://www.who.
int/gho/health_equity/report_2015/en/. Accessed on 07 Apr, 2020
56. Galea S. Mass media. Macro social determinants of population health. New
York, NY: Springer; 2007. p. 275–94.
57. Ghosh D. Effect of mothers’ exposure to electronic mass media on
knowledge and use of prenatal care services: a comparative analysis of
Indian states. Prof Geogr. 2006;58(3):278–93.
58. Uddin MF. Impact of mass media on antenatal care (ANC) utilization in
Bangladesh (Vol. 149): Institute for Population and Social Research (IPSR),
Mahidol University; 2009.
59. Asp G, Pettersson KO, Sandberg J, Kabakyenga J, Agardh A. Associations
between mass media exposure and birth preparedness among women in
southwestern Uganda: a community-based survey. Glob Health Action.
2014;7(1):22904.
60. Zamawe CO, Banda M, Dube AN. The impact of a community driven mass
media campaign on the utilization of maternal healthcare services in rural
Malawi. BMC Pregnancy Childbirth. 2016;16(1):21.
61. Gollust SE, Fowler EF, Niederdeppe J. Television news coverage of public
health issues and implications for public health policy and practice. Annu
Rev Public Health. 2019;40(1):167–85.
62. Gupta S, Yamada G, Mpembeni R, Frumence G, Callaghan-Koru JA,
Stevenson R, et al. Factors associated with four or more antenatal care visits
and its decline among pregnant women in Tanzania between 1999 and
2010. PLoS ONE. 2014;9(7):e101893.
63. Tarekegn SM, Lieberman LS, Giedraitis V. Determinants of maternal
health service utilization in Ethiopia: analysis of the 2011 Ethiopian
Zegeye et al. Tropical Medicine and Health           (2021) 49:53 Page 14 of 15
Demographic and Health Survey. BMC Pregnancy Childbirth.
ns2014;14:161.
64. Yaya S, Okonofua F, Ntoimo L, Udenige O, Bishwajit G. Gender inequity as a
barrier to women’s access to skilled pregnancy care in rural Nigeria: a
qualitative study. Int Health. 2019;11(6):551–60.
65. Singh A, Ram F. Men’s involvement during pregnancy and childbirth:
evidence from Rural Ahmadnagar, India. Popul Rev. 2009;48:83–102.
66. Tsegaye B, Shudura E, Yoseph A, Tamiso A. Predictors of skilled maternal
health services utilizations: a case of rural women in Ethiopia. PLoS ONE.
2021;16(2):e0246237.
67. Lewis S, Lee A, Simkhada P. The role of husbands in maternal health and
safe childbirth in rural Nepal: a qualitative study. BMC Pregnancy Childbirth.
2015;15:162.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Zegeye et al. Tropical Medicine and Health           (2021) 49:53 Page 15 of 15
